Open AccessChemotherapy for Elderly Ovarian Cancer Patients
Author(s) -
Sivraj Muralikrishnan,
Christos Hatzis,
A. Katz,
Alessandro D. Santin,
Peter E. Schwartz,
Maysa Abu-Khalaf
Publication year - 2016
Publication title -
gynecology and obstetrics
Language(s) - English
Resource type - Journals
ISSN - 2161-0932
DOI - 10.4172/2161-0932.1000397
Subject(s) - medicine , discontinuation , carboplatin , regimen , ovarian cancer , hazard ratio , stage (stratigraphy) , chemotherapy , cancer , neutropenia , population , gynecology , surgery , confidence interval , paleontology , environmental health , cisplatin , biology
Ovarian cancer is the most lethal cancer involving the female pelvic reproductive system. Its incidence increases with age and with an aging population, its prevalence should also increase. The goal of our retrospective study is to report our experience in treating women over 65 years of age, with a diagnosis of primary ovarian cancer, using standard intravenous chemotherapy.